Ella Li, Ph.D

Dr. Ella Li is the founding partner of H7 BioCapital, where she leads growth initiatives for healthcare companies through its venture and accelerator arms. Additionally, she serves as an advisor at Pegasus Tech Ventures and is a venture partner at Network VC, specializing in early-stage investment in the life science, biotech and medtech sectors. As the former CEO of ZGC Captial and partner of its U.S. funds, Dr. Li successfully established and managed several VC and fund of funds, including one with portfolio funds such as KPCB, Menlo, Andreessen Horowitz, Accel, and Foundation Capital. Prior to her current positions, she led life science investments at Hanhai BioLabs as CEO.

With over a decade of experience in biotech research, Dr. Li possesses a wealth of knowledge in therapeutic investment opportunities, from discovery to commercialization. Dr. Ella Li earned her postdoctoral fellowship from Harvard Medical School, her Ph.D. from the University of Texas Health Science Center, and her B.S. and M.S. degrees from Peking University. Dr. Li has extensive publications in prestigious journals with IMF over 10 including Nature Communication, Cell Metabolism, Journal of Clinical Investigation, Proceedings of the National Academy of Sciences (PNAS), Molecular Cell, and Diabetes.